1887

Abstract

Epstein–Barr virus (EBV) infection is strongly associated with nasopharyngeal carcinoma, a common cancer in Southeast Asia and certain regions of Africa. However, the dynamics of EBV episome maintenance in infected nasopharyngeal epithelial (NPE) cells remain largely undefined. Here, we report the establishment of a highly efficient cell-free EBV infection method for NPE cells. By using this method, we have defined some of the dynamic events involved in the early stage of EBV infection in NPE cells. We report, for the first time, a rapid loss of EBV copies from infected NPE cells during the first 12–72 h post-infection. The rate of EBV loss slowed at later stages of infection. Live cell imaging revealed that the freshly infected NPE cells were delayed in entry into mitosis compared with uninfected cells. Freshly infected NPE cells transcribed significantly higher levels of lytic EBV genes BZLF1 and BMRF1 yet significantly lower levels of EBER1/2 than stably infected NPE cells. Notably, there were very low or undetectable levels of protein expressions of EBNA1, LMP1, Zta and Rta in freshly infected NPE cells, whereas EBNA1 and LMP1 proteins were readily detected in stable EBV-infected NPE cells. The kinetics of EBV loss and the differential EBV gene expression profiles between freshly and stably infected NPE cells are in line with the suggestion of epigenetic changes in the EBV genome that affect viral gene expression and the adaptation of host cells to EBV infection to maintain persistent EBV infection in NPE cells.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001243
2019-02-28
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/100/6/999.html?itemId=/content/journal/jgv/10.1099/jgv.0.001243&mimeType=html&fmt=ahah

References

  1. Young LS, Rickinson AB. Epstein-barr virus: 40 years on. Nat Rev Cancer 2004; 4:757–768 [View Article][PubMed]
    [Google Scholar]
  2. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995; 333:693–698 [View Article][PubMed]
    [Google Scholar]
  3. Imai S, Nishikawa J, Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 1998; 72:4371–4378[PubMed]
    [Google Scholar]
  4. Shannon-Lowe C, Adland E, Bell AI, Delecluse HJ, Rickinson AB et al. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol 2009; 83:7749–7760 [View Article][PubMed]
    [Google Scholar]
  5. Tsang CM, Zhang G, Seto E, Takada K, Deng W et al. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization. Int J Cancer 2010; 127:1570–1583 [View Article][PubMed]
    [Google Scholar]
  6. Li HM, Man C, Jin Y, Deng W, Yip YL et al. Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase. Int J Cancer 2006; 119:1567–1576 [View Article][PubMed]
    [Google Scholar]
  7. Tsang CM, Yip YL, Lo KW, Deng W, To KF et al. Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells. Proc Natl Acad Sci USA 2012; 109:E3473E3482 [View Article][PubMed]
    [Google Scholar]
  8. Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive. J Virol 1998; 72:7075–7083[PubMed]
    [Google Scholar]
  9. Leight ER, Sugden B. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol 2001; 21:4149–4161 [View Article][PubMed]
    [Google Scholar]
  10. Nanbo A, Ohashi M, Yoshiyama H, Ohba Y. The role of transforming growth factor β in cell-to-cell contact-mediated Epstein-Barr virus transmission. Front Microbiol 2018; 9:984 [View Article][PubMed]
    [Google Scholar]
  11. Hau PM, Deng W, Jia L, Yang J, Tsurumi T et al. Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells. J Virol 2015; 89:652–668 [View Article][PubMed]
    [Google Scholar]
  12. Ruf IK, Lackey KA, Warudkar S, Sample JT. Protection from interferon-induced apoptosis by Epstein-Barr virus small RNAs is not mediated by inhibition of PKR. J Virol 2005; 79:14562–14569 [View Article][PubMed]
    [Google Scholar]
  13. Wong HL, Wang X, Chang RC, Jin DY, Feng H et al. Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress. Mol Carcinog 2005; 44:92–101 [View Article][PubMed]
    [Google Scholar]
  14. Iwakiri D, Eizuru Y, Tokunaga M, Takada K. Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an epstein-barr virus-encoded small RNA. Cancer Res 2003; 63:7062–7067[PubMed]
    [Google Scholar]
  15. Dhar V, Schildkraut CL. Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats. Mol Cell Biol 1991; 11:6268–6278 [View Article][PubMed]
    [Google Scholar]
  16. Leight ER, Sugden B, Light ER. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon. J Virol 2001; 75:10709–10720 [View Article][PubMed]
    [Google Scholar]
  17. Temple RM, Zhu J, Budgeon L, Christensen ND, Meyers C et al. Efficient replication of Epstein-Barr virus in stratified epithelium in vitro. Proc Natl Acad Sci USA 2014; 111:16544–16549 [View Article][PubMed]
    [Google Scholar]
  18. Lieberman PM. Keeping it quiet: chromatin control of gammaherpesvirus latency. Nat Rev Microbiol 2013; 11:863–875 [View Article][PubMed]
    [Google Scholar]
  19. Kang D, Skalsky RL, Cullen BR. EBV BART microRNAs target multiple pro-apoptotic cellular genes to promote epithelial cell survival. PLoS Pathog 2015; 11:e1004979 [View Article][PubMed]
    [Google Scholar]
  20. Saridakis V, Sheng Y, Sarkari F, Holowaty MN, Shire K et al. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol Cell 2005; 18:25–36 [View Article][PubMed]
    [Google Scholar]
  21. Dziadzio M, Smith RE, Abraham DJ, Black CM, Denton CP. Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score. Rheumatology 2005; 44:1518–1524 [View Article][PubMed]
    [Google Scholar]
  22. Ayatollahi M, Geramizadeh B, Samsami A. Transforming growth factor beta-1 influence on fetal allografts during pregnancy. Transplant Proc 2005; 37:4603–4604 [View Article][PubMed]
    [Google Scholar]
  23. Deng W, Tsao SW, Lucas JN, Leung CS, Cheung AL. A new method for improving metaphase chromosome spreading. Cytometry A 2003; 51:46–51 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001243
Loading
/content/journal/jgv/10.1099/jgv.0.001243
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error